Skip to content
★ Sign in to follow
BA
Total declarations
49
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (28 ops.)
€10.1M

Latest filing published 12 Jun 2023 for GoodRx Holdings, Inc., €35k.

Filing timeline

BuySale
Babak Azad

Insider track record

Disclosed buys
0
Disclosed sells
28
Signal history

Babak Azad: trading record in brief

All filings by Babak Azad on record concern GoodRx Holdings, Inc. In total, 49 filings cover trades dated from 1 April 2021 to 8 June 2023.

The open-market record consists of 28 sales worth €10.1M, with no purchase. Besides market trades, the filings include 3 share grants and 18 option exercises.

On 12 June 2023 came the latest disclosure, a share grant for €35k in GoodRx Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Babak Azad

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations49 total
  • ◆
    See RemarksExecutivesGoodRx Holdings, Inc.
    38,168 USD2SEC
    7,055 shares@ US$5.410.3% of flowClass A Common StockSEC:0000950170-23-027563:1
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    0SEC
    20,401 sharesClass A Common StockSEC:0000950170-23-027563:0
  • ◆
    See RemarksExecutivesGoodRx Holdings, Inc.
    44,490 USD2SEC
    8,089 shares@ US$5.500.4% of flowClass A Common StockSEC:0000899243-23-007774:1
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    0SEC
    20,402 sharesClass A Common StockSEC:0000899243-23-007774:0
  • ◆
    See RemarksExecutivesGoodRx Holdings, Inc.
    35,134 USD2SEC
    7,055 shares@ US$4.980.3% of flowClass A Common StockSEC:0000899243-22-038249:1
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    0SEC
    20,401 sharesClass A Common StockSEC:0000899243-22-038249:0
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    154,419 USD20SEC
    3,770 shares@ US$40.961.2% of flowClass A Common StockSEC:0000899243-21-047893:1
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    355,662 USD20SEC
    8,430 shares@ US$42.192.7% of flowClass A Common StockSEC:0000899243-21-047893:2
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    12,804 USD20SEC
    300 shares@ US$42.680.1% of flowClass A Common StockSEC:0000899243-21-047893:3
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    74,250 USD2SEC
    12,500 shares@ US$5.944.5% of flowClass A Common StockSEC:0000899243-21-047893:0
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    29,700 USD2SEC
    5,000 shares@ US$5.941.8% of flowClass A Common StockSEC:0000899243-21-045268:0
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    493,389 USD20SEC
    11,700 shares@ US$42.173.6% of flowClass A Common StockSEC:0000899243-21-044381:1
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    34,504 USD20SEC
    800 shares@ US$43.130.3% of flowClass A Common StockSEC:0000899243-21-044381:2
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    74,250 USD2SEC
    12,500 shares@ US$5.944.4% of flowClass A Common StockSEC:0000899243-21-044381:0
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    306,825 USD20SEC
    7,500 shares@ US$40.912.3% of flowClass A Common StockSEC:0000899243-21-040104:1
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    44,550 USD2SEC
    7,500 shares@ US$5.942.7% of flowClass A Common StockSEC:0000899243-21-040104:0
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    72,796 USD20SEC
    1,801 shares@ US$40.420.5% of flowClass A Common StockSEC:0000899243-21-035755:1
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    140,828 USD20SEC
    3,400 shares@ US$41.421.0% of flowClass A Common StockSEC:0000899243-21-035755:2
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    310,426 USD20SEC
    7,299 shares@ US$42.532.2% of flowClass A Common StockSEC:0000899243-21-035755:3
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    74,250 USD2SEC
    12,500 shares@ US$5.944.3% of flowClass A Common StockSEC:0000899243-21-035755:0
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    206,500 USD17SEC
    6,250 shares@ US$33.041.5% of flowClass A Common StockSEC:0000899243-21-033166:1
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    37,125 USD2SEC
    6,250 shares@ US$5.942.2% of flowClass A Common StockSEC:0000899243-21-033166:0
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    196,063 USD17SEC
    6,250 shares@ US$31.371.4% of flowClass A Common StockSEC:0000899243-21-032504:1
  • ◇
    See RemarksExecutivesGoodRx Holdings, Inc.
    37,125 USD2SEC
    6,250 shares@ US$5.942.2% of flowClass A Common StockSEC:0000899243-21-032504:0
  • ▼
    See RemarksExecutivesGoodRx Holdings, Inc.
    412,250 USD20SEC
    12,500 shares@ US$32.983.0% of flowClass A Common StockSEC:0000899243-21-028120:1

25 of 49 declarations